China Money Network
Login
Join

Chinese Biotech Firm Ascletis Leads Series E Round In American Pharma 3-V Biosciences

  • February 13, 2019 — 12:22 CST

This Data Is Locked!

This area is available only to Subscribers.

An affiliate of Hong Kong-listed Chinese biotech company Ascletis Pharma has led a US$18 million series E financing round in San Francisco-based clinical-stage pharmaceutical firm... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: